Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 (PPARγ2): Beta-cell function and insulin sensitivity;Der polymorphismus Pro12Ala im peroxisomenproliferator-aktivierten rezeptor γ2 (PPARγ2): Betazell-funktion und insulinsensitivität

Deutsche Medizinische Wochenschrift

Volumn 126, Issue 20, 2001, Pages 580-584

  Fritsche, A ^a   Madaus, A ^a   Tschritter, O ^a   Ozeker M ^a   Wulle, E L ^a   Machicao, F ^a   Haring H ^a   Stumvoll, M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCOSE; ISOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; HETEROZYGOTE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL;

ADULT; ALANINE; ALLELES; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; GLUCOSE TOLERANCE TEST; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0035907084     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14103     Document Type: Article

References (29)

1. Molecular genetics of diabetes mellitus
2. The common PPAR gamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
3. PPARgamma, the ultimate thrifty gene
4. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations
5. The genetics of obesity in humans
6. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
7. Expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in normal human pancreatic islet cells
8. Characterisation of beta-cell dysfunction of impaired glucose tolerance. Evidence for impairment of incretin-induced insulin secretion
9. A novel hyperglycemic clamp for characterization of islet function in humans: Assessment of three different secretagogues, maximal insulin response and reproducibility
10. Molecular physiology and genetics of NIDDM. Importance of metabolic staging
11. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM)
12. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes
13. The PPARgamma2 polymorphism Pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients
14. Insulin action, diabetogenes, and the cause of type II diabetes
15. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function
16. The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects
17. Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins
18. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: Relation to insulin action
19. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM
20. Evolution of beta-cell dysfunction in impaired glucose tolerance and diabetes
21. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
22. The Pro12Ala polymorphism in the peroxisome proliferator activated receptor g2 gene is associated with increased antilipolytic insulin sensitivity
23. Type II diabetes: Clinical aspects of molecular biological studies
24. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance
25. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests
26. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes. Influence of body weight
27. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
28. Monogenic diabetes mellitus in youth. The MODY syndromes
29. Pathogenesis of non-insulin-dependent diabetes mellitus